| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 03/11/2014 | US8669072 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2014 | CA2784180C Seven-membered ring compound and pharmaceutical use therefor |
| 03/06/2014 | WO2014033196A1 Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use |
| 03/06/2014 | WO2014032732A1 Halogenated benzoxazines and use thereof |
| 03/06/2014 | WO2014007951A3 Substituted tricyclic compounds as fgfr inhibitors |
| 03/06/2014 | US20140066433 Fused heterocyclic derivatives as s1p modulators |
| 03/05/2014 | CN103619852A Polymorph of rifaximin and process for the preparation thereof |
| 03/05/2014 | CN103619844A N-substituted hetero-bicyclic compounds and derivatives for combating animal pests |
| 03/04/2014 | US8664396 Photoluminescent metal complexes for protein staining |
| 03/04/2014 | US8664249 Tetrasubstituted benzenes |
| 02/27/2014 | WO2014029684A1 Pesticidally active pyridyl- and pyrimidyl- substituted pyrazole derivatives |
| 02/27/2014 | WO2014029251A1 Benazepine compound and application thereof |
| 02/27/2014 | WO2014029250A1 Benazepine compound and application thereof |
| 02/27/2014 | US20140058098 Benzoxazepin pi3k inhibitor compounds and methods of use |
| 02/27/2014 | US20140057902 Diazepinone derivatives |
| 02/27/2014 | US20140057893 Substituted cycloproply compounds, compositions containing such compounds and methods of treatment |
| 02/26/2014 | EP2699580A2 Diazonamide analogs |
| 02/26/2014 | EP2699574A1 Bicyclic heterocycle compounds and their uses in therapy |
| 02/26/2014 | EP2699571A2 Materials for organic electroluminescent devices |
| 02/26/2014 | CN103601736A Preparation method for rifampin by using micro-reaction apparatus |
| 02/26/2014 | CN102659495B Method for separating chiral drugs by using oligonucleotides |
| 02/26/2014 | CN102471317B Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 02/26/2014 | CN102382129B Spirocycles-substituted phosphodiesterase inhibitor |
| 02/25/2014 | US8658670 Methods and compounds for treatment of clostridium based infection |
| 02/25/2014 | US8658654 Receptor-type kinase modulators and methods of use |
| 02/25/2014 | US8658638 Mineralocorticoid receptor antagonist and methods of use |
| 02/25/2014 | US8658637 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| 02/20/2014 | WO2014028384A1 Inhibitors of human immunodeficiency virus replication |
| 02/20/2014 | WO2014026467A1 Bicyclic substituted pyrimidine compounds |
| 02/20/2014 | US20140051702 Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis |
| 02/20/2014 | US20140051692 Inhibitors of Human Immunodeficiency Virus Replication |
| 02/20/2014 | US20140051676 Triazine-oxadiazoles |
| 02/20/2014 | US20140050783 Methods and compositions for sleep disorders and other disorders |
| 02/19/2014 | EP2698372A1 Novel imidazo-oxazine compound or salt thereof |
| 02/19/2014 | EP2697233A1 Macrocyclic triazine compounds for the treatment of hepatitis c |
| 02/19/2014 | EP2697232A1 6,7 - dihydroimidazo [2, 1 - b][1, 3]oxazine bactericides |
| 02/19/2014 | EP2697230A1 Compounds for the treatment of hepatitis c |
| 02/19/2014 | EP2697226A1 Compounds for electronic devices |
| 02/19/2014 | EP2697225A1 Materials for electronic devices |
| 02/19/2014 | CN103596962A Processes and intermediates in the preparation of morphine analogs via N-demethylation of N-oxides using cyclodehydration reagents |
| 02/19/2014 | CN103596961A Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors |
| 02/19/2014 | CN103596960A 6,7-dihydroimidazo [2, 1-b] [1, 3] oxazine bactericides |
| 02/19/2014 | CN102372726B Preparation method for sirolimus coarse crystal |
| 02/18/2014 | USRE44768 Rapamycin hydroxyesters |
| 02/18/2014 | US8653098 Pyrazolopyridine PI3K inhibitor compounds and methods of use |
| 02/18/2014 | US8653096 Chemokine receptor antagonists and methods of use thereof |
| 02/18/2014 | US8653065 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder |
| 02/18/2014 | US8652479 Antibody-drug conjugates and methods |
| 02/13/2014 | WO2014024056A1 Pyrrolidine derivatives with antibacterial properties |
| 02/13/2014 | WO2014023815A1 New antibacterial compounds |
| 02/13/2014 | WO2014023814A1 New antibacterial compounds |
| 02/13/2014 | WO2014023708A1 Substituted hetero-azepinones |
| 02/13/2014 | WO2014023385A1 Pyridopyrimidine derivatives as protein kinase inhibitors |
| 02/13/2014 | US20140046055 Compounds and methods for inhibiting mitotic progression |
| 02/13/2014 | US20140046053 Neprilysin inhibitors |
| 02/13/2014 | US20140045860 Small molecule inhibitors for treating parasitic infections |
| 02/13/2014 | US20140045831 Bicyclic heterocycle compounds and their uses in therapy |
| 02/13/2014 | US20140045830 Cyclic urea- or lactam-substituted quinoxaline-type piperidine compounds and uses thereof |
| 02/13/2014 | US20140045828 Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| 02/13/2014 | US20140045821 Protein kinase d inhibitors |
| 02/13/2014 | US20140045800 Tetracyclic inhibitors of fatty acid amide hydrolase |
| 02/12/2014 | EP2694520A1 Regioselective acylation of rapamycin at the c-42 position |
| 02/12/2014 | EP2694519A1 Novel heterocyclic compounds as modulators of sphingolipid signaling and uses thereof |
| 02/12/2014 | EP2694507A1 N-substituted hetero-bicyclic compounds and derivatives for combating animal pests |
| 02/12/2014 | EP2693882A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 02/12/2014 | CN103582645A Diazonamide analogs |
| 02/12/2014 | CN103582630A Neprilysin inhibitors |
| 02/12/2014 | CN103570744A Quinazoline alkaloid compound, preparation method thereof and application of quinazoline alkaloid compound as tumor cell growth inhibitor |
| 02/12/2014 | CN103570737A Heterocyclic compounds, organic light-emitting device comprising the same and organic light-emitting display |
| 02/12/2014 | CN103570721A Triazolopyrazine(one) and isoxazolopiperidone compounds |
| 02/12/2014 | CN103570630A Heterocyclic nitrogen derivative and application thereof in medicines |
| 02/11/2014 | US8648070 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments |
| 02/06/2014 | WO2014022752A1 Macrocycles as pim inhibitors |
| 02/06/2014 | WO2014022343A1 7-hydroxy-indolinyl antagonists of p2y1 receptor |
| 02/06/2014 | WO2014021281A1 Partially saturated nitrogen-containing heterocyclic compound |
| 02/06/2014 | WO2014020405A1 Cyclic urea- or lactam-substituted quinoxaline-type piperidine compounds and the uses thereof |
| 02/06/2014 | US20140039215 4-Biphenyl-substituted pyrazolidin-3,5-dione derivatives |
| 02/06/2014 | US20140038955 Heteroaryl amide analogues as p2x7 antagonists |
| 02/06/2014 | US20140038926 Heteroaryl-Ketone Fused Azadecalin Glucocorticoid Receptor Modulators |
| 02/05/2014 | EP2691413A1 Macrocyclic compounds and methods for their production |
| 02/05/2014 | EP2691412A1 Macrocyclic compound and methods for its production |
| 02/05/2014 | EP2691391A2 Compounds and methods for the treatment of isocitrate dehydrognase related diseases |
| 02/05/2014 | CN103562210A Benzoxazepin compounds selective for pi3k p110 delta and methods of use |
| 02/05/2014 | CN103554135A Chromone structure containing isoxazole norcantharidin derivatives as well as preparation method and application thereof |
| 02/05/2014 | CN103554134A Chromone structure containing isoxazole norcantharidin derivatives as well as preparation method and application thereof |
| 02/05/2014 | CN103554133A Technology for preparing high-purity tacrolimus |
| 02/04/2014 | CA2573969C Oxidative degradation products of atorvastatin calcium |
| 02/04/2014 | CA2491191C Receptor-type kinase modulators and methods of use |
| 01/30/2014 | WO2008019124A8 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 01/30/2014 | US20140031549 Process and Intermediates for the Synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds |
| 01/30/2014 | US20140031544 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 01/30/2014 | US20140031349 Inhibitors of the renal outer medullary potassium channel |
| 01/30/2014 | US20140031342 6,7-DIHYDROIMIDAZO [2,1-b] [1,3]OXAZINE BACTERICIDES |
| 01/30/2014 | US20140031340 5-Amino-Oxazepine and 5-Amino-Thiazepane Compounds as Beta Secretase Antagonists and Methods of Use |
| 01/30/2014 | US20140031339 Inhibitors of leukotriene production |
| 01/30/2014 | US20140031333 Compounds and compositions as c-kit kinase inhibitors |
| 01/30/2014 | DE102013214399A1 Heterocyclische Verbindungen und organische lichtemittierende Vorrichtungen, die diese aufweisen Heterocyclic compounds and organic light emitting devices having these |
| 01/29/2014 | EP2688891A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use |
| 01/29/2014 | EP2516437B1 Disubstituted heteroaryl-fused pyridines |
| 01/29/2014 | EP2493894B1 Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands |